Novanta Inc
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Novanta Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 99.20 $ to 168.80 $ · Last price: 133.60 $ (As of: September 17, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Scientific & Technical Instruments
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| Novanta Inc NOVT | 4.8 | 95.0 | 26.4 | 44.5 | 11.7 | 3.3 | 18.2 |
| Keysight Technologies Inc KEYS | 60.0 | 52.9 | 28.1 | 63.3 | 18.8 | 8.0 | 91.7 |
| Coherent Inc COHR | 58.7 | 130.0 | 34.5 | 37.5 | 13.6 | 23.4 | 186.2 |
| Garmin Ltd GRMN | 53.1 | 30.3 | 22.3 | 60.1 | 24.6 | 15.1 | 18.9 |
| Teledyne Technologies Incorporated TDY | 27.9 | 30.8 | 18.5 | 43.3 | 19.0 | 7.9 | 8.3 |
| MKS Instruments Inc MKSI | 17.5 | 47.7 | 19.3 | 46.9 | 16.1 | 9.6 | 99.6 |
| Fortive Corp FTV | 17.0 | 32.8 | 16.0 | 63.2 | 17.9 | -17.5 | 15.2 |
| Trimble Inc TRMB | 13.4 | 29.4 | 53.7 | 71.8 | 15.9 | -2.6 | -28.0 |
| Cognex Corporation CGNX | 10.1 | 72.9 | 36.4 | 68.9 | 22.3 | 8.7 | 38.9 |
| Median of companies shown | 17.5 | 47.7 | 26.4 | 60.1 | 17.9 | 8.0 | 18.9 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 385 | 33 | 22 | 0.63 | 48 | 259 | 426 |
| 2017 | 521 | 58 | 60 | 1.70 | 63 | 312 | 727 |
| 2018 | 614 | 71 | 49 | 1.38 | 90 | 368 | 720 |
| 2019 | 626 | 55 | 41 | 1.15 | 63 | 417 | 870 |
| 2020 | 591 | 56 | 45 | 1.25 | 140 | 477 | 865 |
| 2021 | 707 | 64 | 50 | 1.41 | 95 | 521 | 1,228 |
| 2022 | 861 | 103 | 74 | 2.06 | 91 | 578 | 1,241 |
| 2023 | 882 | 111 | 73 | 2.02 | 120 | 673 | 1,226 |
| 2024 | 949 | 111 | 64 | 1.77 | 159 | 746 | 1,389 |
| 2025 | 981 | 117 | 54 | 1.47 | 64 | 1,314 | 1,807 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.46 | 31.30 | 238 | 12.50 | 6.90 | 62 | 59 |
| 2025: Q1 | 0.59 | 44.50 | 233 | 1.10 | 9.10 | 32 | 27 |
| 2025: Q2 | 0.12 | -67.30 | 241 | 2.20 | 1.90 | 15 | 12 |
| 2025: Q3 | 0.30 | -44.40 | 248 | 1.40 | 4.30 | 9 | 4 |
| 2025: Q4 | 0.45 | -0.80 | 258 | 8.50 | 6.80 | 9 | 5 |
| 2026: Q1 | 0.51 | -12.70 | 258 | 10.40 | 8.20 | 50 | 46 |
| 2026: Q2 | 0.30 | 150.00 | 266 | 10.30 | 4.70 | 65 | 57 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 5 of our scanner strategies — each hit links to the scanner.
Quality & Balance Sheet
Momentum & Trend
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 3.69 | 3.69 – 3.70 | 1,133 | 12.3% | 3 |
| 12/31/2027 | 4.37 | 4.30 – 4.44 | 1,313 | 18.2% | 3 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly 17.7% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $114.3M |
|---|---|
| Market cap | $4.76B |
| Free cash flow in year ten | $582.5M |
| Terminal value as a share of market value | 64.5% |
For comparison: over the past five years free cash flow shrank by 17.9% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 4.4%
- More than 10% revenue growth is expected for the coming year 6.8%
- Share count grows by less than 3% a year 0.7%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 8.2%
- Gross margin at 40% or higher and without meaningful erosion 41.6%
- Goodwill from acquisitions does not grow faster than revenue 35.8%
- Net debt below twice EBITDA 39 m net cash
- Operating cash flow covers the profits of the last three years 152 m
- Return on capital at 15% or higher, or up versus two years ago 7.3%
- Insiders hold at least 10% or are net buyers 0.8%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
8/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 11.0%
- Exp. sales growth 3Y > 5% 15.7%
- EBIT growth 10Y > 5% 15.1%
- Exp. EBIT growth 3Y > 5% 72.5%
- Net debt < 4x EBIT -0.3x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 22.2%
- Return on equity > 15% 11.1%
- ROCE > 15% 7.3%
- Expected return > 10% 74.3%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Secor Thomas N | Director | Sell | 663 | 147.60 | 97,859 |
| Apr 17, 2026 | Matthijs Glastra | CEO | Sell | 6,500 | 130.05 | 845,325 |
The company
About the Company
Novanta Inc. bietet gemeinsam mit ihren Tochtergesellschaften Lösungen für Präzisionsmedizin, Präzisionsfertigung, Medizin, Robotik und Automatisierung sowie fortschrittliche Chirurgie in den USA und international an.
- CEO Insider Trades (12 Mo.)
- selling own stock
- Employees
- 3,000
- Headquarters
- Bedford, MA
- Address
- 125 Middlesex Turnpike, 01730 Bedford, United States
- Phone
- 781 266 5700
- Website
- novanta.com
- IPO Date
- 01/04/2016
- ISIN
- CA67000B1040
- Stock Split
- 1:3 on 12/29/2010
Management
| Name | Title | Birth Year |
|---|---|---|
| Matthijs Glastra | CEO & Chairman of the Board | 1969 |
| Robert J. Buckley | Chief Financial Officer | 1974 |
| Alexander Manganiello | General Counsel & Corporate Secretary | 1967 |
| Charles G. Ravetto | Co-Chief Operating Officer of Automation Enabling Technologies | 1971 |
| John Lesica | Co-Chief Operating Officer of Medical Solutions | 1976 |
| John Joseph Burke II | Chief Accounting Officer & Corporate Controller | 1982 |
| Sarah Betadam | Chief Information Officer & Chief Information Security Officer | – |
| Nissia Sabri | Senior Vice President of Corporate Development | – |
| Liam Weston | Chief Human Resources Officer | – |
| Heinrich Dreyer | Group President of Medical Solutions | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
- 08/05/2026 NOVANTA INC (NOVT): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
- 07/27/2026 NOVANTA INC (NOVT): Completion of Acquisition or Disposition of Assets; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.